EBV infection of HEK-293 cells is dependent on CR2/CD21 (13), a gp350 cellular receptor, and is thus expected to be susceptible to gp350-specific antibody-mediated EBV neutralization (47, 48). Here, CR2 is linked to Epstein-Barr virus infection.